Geographic Tongue Market Share

Global Geographic Tongue Market Overview

Geographic Tongue Market Size was valued at USD 0.14 Billion in 2023. The Global Geographic Tongue industry is projected to grow from USD 0.26 Billion in 2024 to USD 0.63 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.18% during the forecast period (2024 - 2032).

Geographic tongue or migratory glossitis is a benign condition which is characterized by the inflammation of the tongue. Under normal conditions the tongue is covered by a layer of small bumps-papillae, which tend to be missing in this medical condition. 

The symptoms for geographic tongue are inclusive of general discomfort of the tongue or mouth and soreness or a burning sensation of the tongue, which is often worsened by spicy or acidic foods. The susceptibility of geographic tongue is high in patients with psoriasis. Moreover, it is estimated that the geriatric population is more frequently diagnosed for the same condition. Thus, the increasing prevalence of the psoriasis along with the growing geriatric population are the major drivers for the market growth. 

According to the International Federation of Psoriasis in 2016, approximately 3% of the world’s population suffer from psoriasis accounting to more than 125 million people across the globe. According to the World Health Organization the global geriatric population is growing and is estimated to reach a 1.5 billion by 2050 from 524 million in 2010. Additionally, growing oral healthcare expenditures are estimated to fuel the market growth during the forecast period. However, lack of awareness along with the limited availability of the treatment procedures and low per capita healthcare expenditure in the middle and low income countries are estimated to restrain the market growth during the forecast period.

Geographic Tongue Market Top Key Players

Some of the key players in the geographic tongue market are

• Quest Diagnostics (U.S.)


• Sonic Healthcare (Australia)


• Merck KGaA (Germany)


• Jost Chemical Co. (U.S.)


• Pfizer Inc. (U.S.)


• AstraZeneca (U.S.)


• F. Hoffmann-La Roche Ltd (Switzerland)


• Abbott (U.S.)


• Danaher (U.S.)

Geographic Tongue Market Segment Insights

The Geographic Tongue Market is segmented on the basis of diagnosis, treatment, and end user.

Geographic Tongue Diagnosis Insights

On the basis of the diagnosis, the market is segmented into physical examinations, biopsy, tests, and others. The tests segment is sub-segmented into vitamin B testing, HLA B antigen testing, and others.

Geographic Tongue Treatment Insights

On the basis of the treatment, the market is segmented into topical corticosteroids, zinc supplements, topical anaesthetic, and others.

Geographic Tongue End User Insights

On the basis of the end user, the market is segmented into hospitals & clinics, research organization, diagnostic labs, and others.

Geographic Tongue Regional Insights

America dominates the geographic tongue market owing to the presence of the developed healthcare sector and rising patient population for diseases like psoriasis. Moreover, increasing per capita healthcare expenditure followed by the presence of the developed economies like U.S. and Canada within the region boosts the market growth during the forecast period.

Europe stands second in the geographic tongue market. Rising research and development in healthcare sector, increasing government funding and presence of huge patient population are the major drivers for the market growth within the region. According to a study published in the Archives of Dermatological Research in 2016, the prevalence of the psoriasis in Germany was about 2.5% affecting 2.0 million people within the region.

Asia Pacific region holds the fastest growing market. The region is marked with increasing healthcare expenditures and developing pharmaceutical & biotechnological sector and growing geriatric population. This, along with the presence of the developing economies like India and China provide huge opportunities for the Geographic Tongue Market growth.

The Middle East & Africa hold the least share in the geographic tongue market, which is attributed due the absence of developed healthcare services, especially in the African Region. A majority of the market share within this region is held by the Middle East. This can be attributed due to the huge healthcare expenditures by the developed economies like Kuwait, Qatar, Dubai and others within the region.

Intended Audience

• Pharmaceutical companies


• Biotechnological institutes


• Research and development (R&D) companies


• Medical research laboratories


• Market research and consulting service providers